IL6 and renal cell carcinoma: As for IL6-JAK-STAT3 signaling pathway, consistent with our findings, Wang et al. (2018) also reported that IL-6 and p-STAT3 expressions in renal cell carcinoma tissues was obviously higher compared with adjacent normal tissues.